Follow
Hanna Eriksson
Hanna Eriksson
M.D. Ph.D., Dept. of Oncology and Pathology, Karolinska Institutet, Karolinska Universtiy Hospital
Verified email at ki.se
Title
Cited by
Cited by
Year
A retrospective analysis of patients with bullous pemphigoid treated with methotrexate
P Kjellman, H Eriksson, P Berg
Archives of dermatology 144 (5), 612-616, 2008
862008
Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden
H Eriksson, J Lyth, E Månsson-Brahme, M Frohm-Nilsson, C Ingvar, ...
European journal of cancer 49 (12), 2705-2716, 2013
842013
Hereditary uveal melanoma: A report of a germline mutation in BAP1
V Höiom, D Edsgärd, H Helgadottir, H Eriksson, C All‐Ericsson, ...
Genes, Chromosomes and Cancer 52 (4), 378-384, 2013
692013
Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population‐based study
H Eriksson, M Frohm‐Nilsson, J Järås, L Kanter‐Lewensohn, P Kjellman, ...
British Journal of Dermatology 172 (1), 175-186, 2015
612015
Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden
H Eriksson, J Lyth, E Månsson-Brahme, M Frohm-Nilsson, C Ingvar, ...
J Clin Oncol 32 (13), 1356-1364, 2014
572014
Trends in cutaneous malignant melanoma in Sweden 1997–2011: thinner tumours and improved survival among men
J Lyth, H Eriksson, J Hansson, C Ingvar, M Jansson, J Lapins, ...
British Journal of Dermatology 172 (3), 700-706, 2015
402015
BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastases
H Eriksson, A Zebary, I Vassilaki, K Omholt, M Ghaderi, J Hansson
JAMA dermatology 151 (4), 410-416, 2015
342015
Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study
TML Andersson, H Eriksson, J Hansson, E Månsson-Brahme, ...
Cancer epidemiology 38 (1), 93-99, 2014
282014
Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management
H Eriksson, M Frohm-Nilsson, MA Hedblad, H Hellborg, ...
Acta Dermato-Venereologica 93 (4), 411-416, 2013
282013
Reduced disease‐specific survival following a diagnosis of multiple primary cutaneous malignant melanomas—a nationwide, population‐based study
D Utjés, J Lyth, J Lapins, H Eriksson
International Journal of Cancer 141 (11), 2243-2252, 2017
182017
The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility
R Tuominen, PG Engström, H Helgadottir, H Eriksson, P Unneberg, ...
Genes, Chromosomes and Cancer 55 (7), 601-611, 2016
172016
Risk of cutaneous malignant melanoma in patients with celiac disease: A population-based study
B Lebwohl, H Eriksson, J Hansson, PHR Green, JF Ludvigsson
Journal of the American Academy of Dermatology 71 (2), 245-248, 2014
172014
Prognostic factors and disease‐specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden
C Simberg‐Danell, J Lyth, E Månsson‐Brahme, M Frohm‐Nilsson, ...
International Journal of Cancer 139 (3), 543-553, 2016
152016
The proportion cured of patients diagnosed with Stage III–IV cutaneous malignant melanoma in S weden 1990–2007: A population‐based study
H Eriksson, J Lyth, TML Andersson
International Journal of Cancer 138 (12), 2829-2836, 2016
122016
Varannan timme får en svensk ett nytt malignt melanom: Incidens, utfall och prevention
C Ingvar, H Eriksson
Läkartidningen 114 (19), 884-886, 2017
42017
Clinical and epidemiological studies on prognostic and predicitve factors in cutaneous melanoma
H Eriksson
PQDT-Global, 2013
22013
Dissecting genetic heterogeneity in stage III cutaneous malignant melanoma with spatially resolved transcriptomics.
H Eriksson, K Thrane, J Maaskola, J Hansson, J Lundeberg
Journal of Clinical Oncology 36 (15_suppl), e21587-e21587, 2018
2018
Exosomal microRNAs as putative predictive biomarkers for targeted therapy in stage IV cutaneous malignant melanoma (CMM).
H Eriksson, W Lohcharoenkal, F Costa-Svedman, E Sonkoly, SE Brage, ...
Journal of Clinical Oncology 34 (15_suppl), 9579-9579, 2016
2016
Prognosis among immigrants diagnosed with cutaneous malignant melanoma in Sweden-a nationwide population-based study
C Simberg-Danell, J Lyth, E Månsson-Brahme, M Frohm-Nilsson, ...
Pigment Cell & Melanoma Research 27 (6), 1189-1190, 2014
2014
Su1438 Risk of Cutaneous Malignant Melanoma in Celiac Disease: A Population-Based Study
B Lebwohl, H Eriksson, J Hansson, PH Green, J Ludvigsson
Gastroenterology 5 (146), S-469, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20